Performance analysis of Altimmune (ALT)
Annual Return
Over the past 3 years, ALT has had an average annual return of -3.58%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, ALT has had an average annual return of -21.20%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ALT has had an average annual return of -34.58%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Oct 6, 2005, ALT has had an average annual return of -22.34%, underperforming the benchmark SPY, which returned +11.26% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.39% | -49.62% | -36.06% | -31.58% | +79.88% | -18.75% | +494.29% | -7.89% | -96.55% | -76.06% | +69.75% | +4.95% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | ||
| -2.67% | +66.06% | -11.80% | -69.98% | +115.82% | -14.79% | -41.77% | -46.69% | +4.08% | +1.71% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +53.73% | -22.33% | -28.75% | -15.79% | +16.67% | +0% | -7.14% | -22.39% | |||||
| 2025 | -7.52% | -0% | -25.20% | +5.43% | +3.09% | -28.00% | -5.56% | +4.41% | -1.41% | +7.14% | +29.33% | -30.93% | -49.62% |
| 2024 | -16.35% | +28.74% | -16.07% | -35.64% | +14.88% | -11.51% | -4.07% | +5.08% | -8.87% | +10.62% | +26.40% | -15.82% | -36.06% |
| 2023 | -17.11% | -7.54% | -66.52% | +19.23% | -19.35% | -13.33% | -6.15% | -22.95% | +2.13% | -6.25% | +28.89% | +258.62% | -31.58% |
| 2022 | -11.83% | -8.05% | -17.52% | -25.66% | +11.90% | +129.79% | +2.78% | +83.78% | -42.16% | -1.69% | -20.69% | +65.22% | +79.88% |
| 2021 | +26.92% | +11.74% | -11.53% | +2.30% | -12.36% | -22.22% | -7.69% | +64.88% | -24.55% | -4.31% | -3.00% | -12.89% | -18.75% |
| 2020 | -8.57% | +112.50% | -13.24% | -5.08% | +207.14% | +15.12% | +147.98% | -36.46% | -21.79% | -13.11% | +6.60% | -7.96% | +494.29% |
| 2019 | +55.26% | -15.25% | +8% | -1.85% | -15.09% | -2.22% | -0% | -11.36% | -7.69% | -2.78% | -2.86% | +2.94% | -7.89% |
| 2018 | -8.98% | -12.75% | -26.60% | -37.48% | -15.92% | -26.92% | -25.10% | -4.32% | -54.24% | -13.58% | -5.71% | -42.42% | -96.55% |
| 2017 | -3.86% | +12.67% | -9.84% | -10.42% | -41.54% | -24.70% | -21.25% | +0% | -7.95% | +3.50% | -24.57% | +9.86% | -76.06% |
Drawdown analysis of Altimmune (ALT)
The maximum drawdown for the ALT was -99.78%, occurring on Nov 19, 2019. This drawdown has not yet recovered.
The current ALT drawdown is -99.60%.
Since Oct 6, 2005 ALT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.78% | Mar 14, 2006 | 3446 | Nov 19, 2019 | Ongoing | Ongoing | Ongoing |
| -4.98% | Feb 27, 2006 | 5 | Mar 6, 2006 | 3 | Mar 9, 2006 | 8 |
| -2.69% | Oct 28, 2005 | 6 | Nov 7, 2005 | 33 | Dec 23, 2005 | 39 |
| -2.25% | Feb 6, 2006 | 7 | Feb 15, 2006 | 5 | Feb 23, 2006 | 12 |
| -2.24% | Dec 30, 2005 | 4 | Jan 6, 2006 | 16 | Jan 31, 2006 | 20 |
| -1.71% | Oct 6, 2005 | 11 | Oct 21, 2005 | 5 | Oct 28, 2005 | 16 |
| -0.98% | Jan 31, 2006 | 1 | Feb 1, 2006 | 1 | Feb 2, 2006 | 2 |
| -0.71% | Dec 28, 2005 | 1 | Dec 29, 2005 | 1 | Dec 30, 2005 | 2 |
| -0.26% | Feb 23, 2006 | 1 | Feb 24, 2006 | 1 | Feb 27, 2006 | 2 |